Chondrogenic Differentiation of Amniotic Fluid Stem Cells and Their Potential for Regenerative Therapy

Stem Cell Reviews and Reports

Volumn 8, Issue 4, 2012, Pages 1267-1274

  Preitschopf, Andrea ^a   Zwickl, Hannes ^b   Li, Kongzhao ^a,c   Lubec, Gert ^c   Joo, Gabor ^d   Rosner, Margit ^a   Hengstschläger, Markus ^a   Mikula, Mario ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DANUBE UNIVERSITY KREMS   (Austria)

^c UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Amniotic fluid stem cells; Cartilage; Chondrogenic differentiation; Osteoarthritis; Stem cell based therapy

Indexed keywords

ALLOTRANSPLANTATION; AMNION FLUID; ANIMAL; ARTICLE; ARTICULAR CARTILAGE; CELL DIFFERENTIATION; CHONDROGENESIS; CHONDROPATHY; CYTOLOGY; HUMAN; METABOLISM; METHODOLOGY; REGENERATIVE MEDICINE; STEM CELL; STEM CELL TRANSPLANTATION;

AMNIOTIC FLUID; ANIMALS; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CHONDROGENESIS; HUMANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84870373676     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9405-4     Document Type: Article

References (89)

1. Nehrer, S., & Minas, T. (2000). Treatment of articular cartilage defects. Investigative Radiology, 35, 639-646.
2. Jiang, L., Tian, W., Wang, Y., et al. (2011). Body mass index and susceptibility to knee osteoarthritis: a systematic review and meta-analysis. Joint Bone Spine.
3. Jiang, Y. Z., Zhang, S. F., Qi, Y. Y., Wang, L. L., & Ouyang, H. W. (2011). Cell transplantation for articular cartilage defects: principles of past, present, and future practice. Cell Transplantation, 20, 593-607.
4. Bedi, A., Feeley, B. T., & Williams, R. J., 3rd. (2010). Management of articular cartilage defects of the knee. The Journal of Bone and Joint Surgery. American Volume, 92, 994-1009.
5. Nehrer, S., Dorotka, R., Domayer, S., Stelzeneder, D., & Kotz, R. (2009). Treatment of full-thickness chondral defects with hyalograft C in the knee: a prospective clinical case series with 2 to 7 years' follow-up. The American Journal of Sports Medicine, 37(Suppl 1), 81S-87S.
6. Salzmann, G. M., Sauerschnig, M., Berninger, M. T., et al. (2011). The dependence of autologous chondrocyte transplantation on varying cellular passage, yield and culture duration. Biomaterials, 32, 5810-5818.
7. Schnabel, M., Marlovits, S., Eckhoff, G., et al. (2002). Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis and Cartilage, 10, 62-70.
8. Sakaguchi, Y., Sekiya, I., Yagishita, K., & Muneta, T. (2005). Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis and Rheumatism, 52, 2521-2529.
9. Vinardell, T., Buckley, C. T., Thorpe, S. D., & Kelly, D. J. (2011). Composition-function relations of cartilaginous tissues engineered from chondrocytes and mesenchymal stem cells isolated from bone marrow and infrapatellar fat pad. Journal of Tissue Engineering and Regenerative Medicine, 5, 673-683.
10. Erickson, I. E., Huang, A. H., Chung, C., Li, R. T., Burdick, J. A., & Mauck, R. L. (2009). Differential maturation and structure-function relationships in mesenchymal stem cell- and chondrocyte-seeded hydrogels. Tissue Engineering. Part A, 15, 1041-1052.
11. De Coppi, P., Bartsch, G., Jr., Siddiqui, M. M., et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology, 25, 100-106.
12. Rosner, M., Dolznig, H., Schipany, K., Mikula, M., Brandau, O., & Hengstschlager, M. (2011). Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis. Oncotarget, 2, 705-712.
13. Da Sacco, S., De Filippo, R. E., & Perin, L. (2010). Amniotic fluid as a source of pluripotent and multipotent stem cells for organ regeneration. Current Opinion in Organ Transplantation.
14. Rosner, M., Schipany, K., Gundacker, C., et al. (2012). Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases. European Journal of Clinical Investigation, 42, 677-684.
15. Rosner, M., Mikula, M., Preitschopf, A., Feichtinger, M., Schipany, K., & Hengstschlager, M. (2012). Neurogenic differentiation of amniotic fluid stem cells. Amino Acids, 42, 1591-1596.
16. Rountree, R. B., Schoor, M., Chen, H., et al. (2004). BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biology, 2, e355.
17. Francis-West, P. H., Abdelfattah, A., Chen, P., et al. (1999). Mechanisms of GDF-5 action during skeletal development. Development, 126, 1305-1315.
18. Koyama, E., Shibukawa, Y., Nagayama, M., et al. (2008). A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Developmental Biology, 316, 62-73.
19. Pacifici, M., Koyama, E., & Iwamoto, M. (2005). Mechanisms of synovial joint and articular cartilage formation: recent advances, but many lingering mysteries. Birth Defects Research. Part C, Embryo Today, 75, 237-248.
20. Brunet, L. J., McMahon, J. A., McMahon, A. P., & Harland, R. M. (1998). Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science, 280, 1455-1457.
21. Hartmann, C., & Tabin, C. J. (2001). Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell, 104, 341-351.
22. Iwamoto, M., Higuchi, Y., Koyama, E., et al. (2000). Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development. The Journal of Cell Biology, 150, 27-40.
23. Storm, E. E., Huynh, T. V., Copeland, N. G., Jenkins, N. A., Kingsley, D. M., & Lee, S. J. (1994). Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature, 368, 639-643.
24. Craig, F. M., Bentley, G., & Archer, C. W. (1987). The spatial and temporal pattern of collagens I and II and keratan sulphate in the developing chick metatarsophalangeal joint. Development, 99, 383-391.
25. Bell, D. M., Leung, K. K., Wheatley, S. C., et al. (1997). SOX9 directly regulates the type-II collagen gene. Nature Genetics, 16, 174-178.
26. Kou, I., & Ikegawa, S. (2004). SOX9-dependent and -independent transcriptional regulation of human cartilage link protein. Journal of Biological Chemistry, 279, 50942-50948.
27. Sekiya, I., Tsuji, K., Koopman, P., et al. (2000). SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. Journal of Biological Chemistry, 275, 10738-10744.
28. Zhang, P., Jimenez, S. A., & Stokes, D. G. (2003). Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9. Journal of Biological Chemistry, 278, 117-123.
29. Liu, C. J., Zhang, Y., Xu, K., Parsons, D., Alfonso, D., & Di Cesare, P. E. (2007). Transcriptional activation of cartilage oligomeric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP/p300 coactivators. Frontiers in Bioscience, 12, 3899-3910.
30. Ikeda, T., Kamekura, S., Mabuchi, A., et al. (2004). The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis and Rheumatism, 50, 3561-3573.
31. Archer, C. W., Dowthwaite, G. P., & Francis-West, P. (2003). Development of synovial joints. Birth Defects Research. Part C, Embryo Today, 69, 144-155.
32. Grimshaw, M. J., & Mason, R. M. (2001). Modulation of bovine articular chondrocyte gene expression in vitro by oxygen tension. Osteoarthritis and Cartilage, 9, 357-364.
33. Buckwalter, J. A. (2002). Articular cartilage injuries. Clinical Orthopaedics and Related Research, (pp. 21-37).
34. Goldring, M. B., & Goldring, S. R. (2010). Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Annals of the New York Academy of Sciences, 1192, 230-237.
35. Madry, H., Grun, U. W., & Knutsen, G. (2011). Cartilage repair and joint preservation: medical and surgical treatment options. Deutsches Ärzteblatt International, 108, 669-677.
36. Goldring, M. B., & Goldring, S. R. (2007). Osteoarthritis. Journal of Cellular Physiology, 213, 626-634.
37. Murphy, G., & Nagase, H. (2008). Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nature Clinical Practice Rheumatology, 4, 128-135.
38. Goldring, S. R. (2009). Role of bone in osteoarthritis pathogenesis. Medicine Clinics of North America, 93, 25-35. xv.
39. Schroeppel, J. P., Crist, J. D., Anderson, H. C., & Wang, J. (2011). Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. Histology and Histopathology, 26, 377-394.
40. Gadjanski, I., Spiller, K., & Vunjak-Novakovic, G. (2011). Time-dependent processes in stem cell-based tissue engineering of articular cartilage. Stem Cell Reviews.
41. Zhao, Q., Eberspaecher, H., Lefebvre, V., & De Crombrugghe, B. (1997). Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Developmental Dynamics, 209, 377-386.
42. Ng, L. J., Wheatley, S., Muscat, G. E., et al. (1997). SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Developmental Biology, 183, 108-121.
43. Leung, V. Y., Gao, B., Leung, K. K., et al. (2011). SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genetics, 7, e1002356.
44. Roberts, S., Genever, P., McCaskie, A., & De Bari, C. (2011). Prospects of stem cell therapy in osteoarthritis. Regenerative Medicine, 6, 351-366.
45. Toh, W. S., Lee, E. H., & Cao, T. (2011). Potential of human embryonic stem cells in cartilage tissue engineering and regenerative medicine. Stem Cell Reviews, 7, 544-559.
46. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
47. Liu, T. M., Martina, M., Hutmacher, D. W., Hui, J. H., Lee, E. H., & Lim, B. (2007). Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells, 25, 750-760.
48. Kaviani, A., Perry, T. E., Dzakovic, A., Jennings, R. W., Ziegler, M. M., & Fauza, D. O. (2001). The amniotic fluid as a source of cells for fetal tissue engineering. Journal of Pediatric Surgery, 36, 1662-1665.
49. Prusa, A. R., Marton, E., Rosner, M., Bernaschek, G., & Hengstschlager, M. (2003). Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Human Reproduction, 18, 1489-1493.
50. In't Anker, P. S., Scherjon, S. A., Kleijburg-van der Keur, C., et al. (2003). Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood, 102, 1548-1549.
51. Miranda-Sayago, J. M., Fernandez-Arcas, N., Benito, C., Reyes-Engel, A., Carrera, J., & Alonso, A. (2011). Lifespan of human amniotic fluid-derived multipotent mesenchymal stromal cells. Cytotherapy, 13, 572-581.
52. Kim, K., Doi, A., Wen, B., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467, 285-290.
53. Moschidou, D., Mukherjee, S., Blundell, M. P., et al. (2012). Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Molecular Therapy.
54. Tsai, M. S., Lee, J. L., Chang, Y. J., & Hwang, S. M. (2004). Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Human Reproduction, 19, 1450-1456.
55. Siegel, N., Rosner, M., Unbekandt, M., et al. (2010). Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Human Molecular Genetics, 19, 3320-3331.
56. Valli, A., Rosner, M., Fuchs, C., et al. (2010). Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Oncogene, 29, 966-977.
57. Rosner, M., Siegel, N., Fuchs, C., Slabina, N., Dolznig, H., & Hengstschlager, M. (2010). Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nature Protocols, 5, 1081-1095.
58. Kunisaki, S. M., Jennings, R. W., & Fauza, D. O. (2006). Fetal cartilage engineering from amniotic mesenchymal progenitor cells. Stem Cells and Development, 15, 245-253.
59. Kim, J., Lee, Y., Kim, H., et al. (2007). Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Proliferation, 40, 75-90.
60. Kolambkar, Y. M., Peister, A., Soker, S., Atala, A., & Guldberg, R. E. (2007). Chondrogenic differentiation of amniotic fluid-derived stem cells. Journal of Molecular Histology, 38, 405-413.
61. Arnhold, S., Gluer, S., Hartmann, K., et al. (2011). Amniotic-fluid stem cells: growth dynamics and differentiation potential after a CD-117-based selection procedure. Stem Cells International, 2011, 715341.
62. Park, J. S., Shim, M. S., Shim, S. H., et al. (2011). Chondrogenic potential of stem cells derived from amniotic fluid, adipose tissue, or bone marrow encapsulated in fibrin gels containing TGF-beta3. Biomaterials, 32, 8139-8149.
63. Merino, R., Macias, D., Ganan, Y., et al. (1999). Expression and function of Gdf-5 during digit skeletogenesis in the embryonic chick leg bud. Developmental Biology, 206, 33-45.
64. Storm, E. E., & Kingsley, D. M. (1999). GDF5 coordinates bone and joint formation during digit development. Developmental Biology, 209, 11-27.
65. Narcisi, R., Quarto, R., Ulivi, V., Muraglia, A., Molfetta, L., & Giannoni, P. (2012). TGF beta-1 administration during ex vivo expansion of human articular chondrocytes in a serum-free medium redirects the cell phenotype toward hypertrophy. Journal of Cellular Physiology, 227, 3282-3290.
66. Guo, X., Day, T. F., Jiang, X., Garrett-Beal, L., Topol, L., & Yang, Y. (2004). Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation. Genes & Development, 18, 2404-2417.
67. Day, T. F., Guo, X., Garrett-Beal, L., & Yang, Y. (2005). Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Developmental Cell, 8, 739-750.
68. Yang, Z., Zou, Y., Guo, X. M., et al. (2012). Temporal activation of beta-catenin signaling in the chondrogenic process of mesenchymal stem cells affects the phenotype of the cartilage generated. Stem Cells and Development.
69. Saito, T., Ikeda, T., Nakamura, K., Chung, U. I., & Kawaguchi, H. (2007). S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Reports, 8, 504-509.
70. Yamashita, S., Andoh, M., Ueno-Kudoh, H., Sato, T., Miyaki, S., & Asahara, H. (2009). Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Experimental Cell Research, 315, 2231-2240.
71. Higashikawa, A., Saito, T., Ikeda, T., et al. (2009). Identification of the core element responsive to runt-related transcription factor 2 in the promoter of human type X collagen gene. Arthritis and Rheumatism, 60, 166-178.
72. Soung do, Y., Dong, Y., Wang, Y., et al. (2007). Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation. Journal of Bone and Mineral Research, 22, 1260-1270.
73. Mengshol, J. A., Vincenti, M. P., & Brinckerhoff, C. E. (2001). IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Research, 29, 4361-4372.
74. Kunisaki, S. M., Fuchs, J. R., Steigman, S. A., & Fauza, D. O. (2007). A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. Tissue Engineering, 13, 2633-2644.
75. Khan, W. S., Adesida, A. B., Tew, S. R., Lowe, E. T., & Hardingham, T. E. (2010). Bone marrow-derived mesenchymal stem cells express the pericyte marker 3 G5 in culture and show enhanced chondrogenesis in hypoxic conditions. Journal of Orthopaedic Research, 28, 834-840.
76. Kay, A., Richardson, J., & Forsyth, N. R. (2011). Physiological normoxia and chondrogenic potential of chondrocytes. Frontiers in Bioscience (Elite Edition), 3, 1365-1374.
77. Zelzer, E., Amarilio, R., Viukov, S. V., Sharir, A., Eshkar-Oren, I., & Johnson, R. S. (2007). HIF1 alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development, 134, 3917-3928.
78. Murphy, C. L., Lafont, J. E., & Talma, S. (2007). Hypoxia-inducible factor 2 alpha is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis and Rheumatism, 56, 3297-3306.
79. Hashimoto, S., Creighton-Achermann, L., Takahashi, K., Amiel, D., Coutts, R. D., & Lotz, M. (2002). Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis and Cartilage, 10, 180-187.
80. Yang, D. C., Yang, M. H., Tsai, C. C., Huang, T. F., Chen, Y. H., & Hung, S. C. (2011). Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST. PLoS One, 6, e23965.
81. Lotz, M. K., & Carames, B. (2011). Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA. Nature Reviews. Rheumatology, 7, 579-587.
82. Carames, B., Taniguchi, N., Otsuki, S., Blanco, F. J., & Lotz, M. (2010). Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis and Rheumatism, 62, 791-801.
83. Carames, B., Hasegawa, A., Taniguchi, N., Miyaki, S., Blanco, F. J., & Lotz, M. (2012). Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Annals of the Rheumatic Diseases, 71, 575-581.
84. Shigemitsu, K., Tsujishita, Y., Hara, K., Nanahoshi, M., Avruch, J., Yonezawa, K., & Yonezawa, K. (1999). Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells. Journal of Biological Chemistry, 274, 1058-1065.
85. Toschi, A., Lee, E., Gadir, N., Ohh, M., & Foster, D. A. (2008). Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. Journal of Biological Chemistry, 283, 34495-34499.
86. Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011). mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews Molecular Cell Biology, 12, 21-35.
87. Phornphutkul, C., Wu, K. Y., Auyeung, V., Chen, Q., & Gruppuso, P. A. (2008). mTOR signaling contributes to chondrocyte differentiation. Developmental Dynamics, 237, 702-712.
88. Qureshi, H. Y., Ahmad, R., Sylvester, J., & Zafarullah, M. (2007). Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in human chondrocytes. Cellular Signalling, 19, 1643-1651.
89. Starkman, B. G., Cravero, J. D., Delcarlo, M., & Loeser, R. F. (2005). IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK. Biochemistry Journal, 389, 723-729.